Aenova
UKWho owns Aenova?
Aenova is a British Pharma company, now owned by Kuhne Holding, which acquired it in 2024 from BC Partners.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Key facts
- ·Fully exited in 2024 to Kuhne Holding.
- ·Average hold across 2 realized cycles: 10 years.
Ownership history
2 ownership periods
Bridgepoint sold Aenova to BC Partners in 2012 after 7 years.
BC Partners sold Aenova to Kuhne Holding in 2024 after 12 years.
More from BC European Capital IX
Other portfolio companies in the same fund.
Italy
Ireland
France
GermanyMore PE-backed in Pharma
Comparable pharma deals from other GPs.
US
SpainQuestions
Who owns Aenova?
Aenova is now owned by Kuhne Holding, which acquired it in 2024 from BC Partners.
When did Kuhne Holding acquire Aenova?
Kuhne Holding acquired Aenova in 2024, buying from BC Partners.
Who did Aenova sell to?
BC Partners sold Aenova to Kuhne Holding in 2024 (Trade Sale). Bridgepoint sold Aenova to BC Partners in 2012 (Secondary).
Who has owned Aenova over time?
Aenova has been through 2 private-equity ownership periods: Bridgepoint · via Europe VII (BE VII) · 2005–2012 · sold to BC Partners · (Secondary); BC Partners · via BC European Capital IX · 2012–2024 · sold to Kuhne Holding · (Trade Sale).